Sarah Rutherford, MD, Weill Cornell Medical College
Advertisement
Articles by Sarah Rutherford, MD, Weill Cornell Medical College
Advertisement
Latest Updated Articles
ASH 2020 Updates in Relapsed/Refractory B-Cell LymphomasPublished: January 22nd 2021 | Updated:
ASH 2020 Updates in CLLPublished: January 22nd 2021 | Updated:
ASH 2020 Updates in Non-CLL B-Cell LymphomasPublished: January 22nd 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
2
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
3
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
4
Orca-T With Reduced-Intensity Conditioning Yields Robust Efficacy in Hematologic Malignancies
5